Annovis Bio, Inc. (07X)
Market Open
3 Mar, 07:04
XFRA 
€
2. 24
+0.01
+0.45%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
-5.14 Eps
€ 2.23
Previous Close Day Range
2.24 2.24
Year Range
1.05 4.61
Want to track 07X and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
07X earnings report is expected in 16 days (19 Mar 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
07X Earnings Reports FAQ
What is the earnings per share (EPS) for 07X?
The current EPS is -5.14.
What is the company's earnings growth rate?
Annovis Bio, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-03-19, based on the 07X's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Annovis Bio, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 07X at this time, as Annovis Bio, Inc has no recent EPS data to calculate it.
